SPP1 Overexpression Is Associated with Poor Outcomes in ALK Fusion Lung Cancer Patients without Receiving Targeted Therapy

Scientists screened a total of 521 tumor specimens from Chinese patients with lung cancer for anaplastic lymphoma receptor tyrosine kinase fusion by immunohistochemistry and confirmed by fluorescence in situ hybridization.